Vertex Pharmaceuticals Q4 EPS $3.37 Beats $3.29 Estimate, Sales $2.07B Beat $2.00B Estimate

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $3.37 per share which beat the analyst consensus estimate of $3.29 by 2.43 percent. This is a 34.26 percent increase over earnings of $2.51 per share from the same period last year. The company reported quarterly sales of $2.07 billion which beat the analyst consensus estimate of $2.00 billion by 3.60 percent. This is a 27.27 percent increase over sales of $1.63 billion the same period last year.